Literature DB >> 3876961

Hepatitis B surface antigen specific cytotoxic T lymphocyte activity in hepatitis B virus infection.

S Onishi, T Saibara, K Ito.   

Abstract

Cytotoxic T lymphocyte (CTL) activity against HBs antigen (HBsAg)-coated autologous mononuclear cells as target cells was examined in hepatitis B virus infection. Target cells were prepared by coincubation of mononuclear cells with purified HBsAg in 0.5 mM CrCl3. The distribution and uniformity amounts of HBsAg on target cells was shown by immune fluorescence and by analyzing the fluorescence intensity with a fluorescent activated cell sorter. CTL activity was detected in 7 of 9 patients with acute hepatitis type B, in 4 of 11 chronic active hepatitis type B, in none of 8 healthy HBsAg carriers, and in none of 22 healthy volunteers. The antigen specificity of the cytotoxicity was confirmed by a blocking experiment with purified HBsAg and by cold target inhibition with HBsAg or bovine serum albumin (irrelevant antigen) coupled cold target cells. CTL lysed HBsAg coupled allogeneic target cells that shared HLA-A or B locus antigens. This finding suggests that HLA restriction may be involved in the killing mechanism. This HBsAg specific CTL clone may participate in the immunopathogenesis of hepatitis B virus infection.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3876961     DOI: 10.1007/bf02774743

Source DB:  PubMed          Journal:  Gastroenterol Jpn        ISSN: 0435-1339


  23 in total

1.  The agglutination and sensitization of red cells by metallic cations: interactions between multivalent metals and the red-cell membrane.

Authors:  J H JANDL; R L SIMMONS
Journal:  Br J Haematol       Date:  1957-01       Impact factor: 6.998

2.  Cellular immunity and hepatitis-associated, Australia antigen liver disease.

Authors:  F J Dudley; R A Fox; S Sherlock
Journal:  Lancet       Date:  1972-04-01       Impact factor: 79.321

3.  Chronic hepatitis--migration inhibition of leukocytes in the presence of Australia antigen.

Authors:  K Ito; J Nakagawa; Y Okimoto; H Nakano
Journal:  N Engl J Med       Date:  1972-05-04       Impact factor: 91.245

4.  Enhanced in vitro cell-mediated cytotoxicity in chronic hepatitis B virus infection: absence of specificity for virus-expressed antigen on target cell membranes.

Authors:  J L Dienstag; A K Bhan
Journal:  J Immunol       Date:  1980-11       Impact factor: 5.422

5.  Transfer factor in treating hepatitis B (cont.)

Authors:  M Sano; T Takeuchi; M Adachi; Y Tamai; K Ito
Journal:  N Engl J Med       Date:  1977-01-06       Impact factor: 91.245

6.  Structural relationships between the surface antigens of ground squirrel hepatitis virus and human hepatitis B virus.

Authors:  W H Gerlich; M A Feitelson; P L Marion; W S Robinson
Journal:  J Virol       Date:  1980-12       Impact factor: 5.103

7.  Liver cell surface localization of hepatitis B antigen and of immunoglobulins in acute and chronic hepatitis and in liver cirrhosis.

Authors:  A Alberti; G Realdi; F Tremolada; G P Spina
Journal:  Clin Exp Immunol       Date:  1976-09       Impact factor: 4.330

8.  Relationship between expression of hepatitis B virus antigens in isolated hepatocytes and autologous lymphocyte cytotoxicity in patients with chronic hepatitis B virus infection.

Authors:  N V Naumov; M Mondelli; G J Alexander; R S Tedder; A L Eddleston; R Williams
Journal:  Hepatology       Date:  1984 Jan-Feb       Impact factor: 17.425

9.  A monoclonal antibody reactive with the human cytotoxic/suppressor T cell subset previously defined by a heteroantiserum termed TH2.

Authors:  E L Reinherz; P C Kung; G Goldstein; S F Schlossman
Journal:  J Immunol       Date:  1980-03       Impact factor: 5.422

10.  Cellular immunity to the hepatitis B virion in acute hepatitis type B.

Authors:  G Fattovich; A Alberti; C Crivellaro; P Pontisso; F Noventa; G Realdi
Journal:  Clin Exp Immunol       Date:  1983-09       Impact factor: 4.330

View more
  2 in total

1.  Development of HBsAg-binding aptamers that bind HepG2.2.15 cells via HBV surface antigen.

Authors:  Jia Liu; Yan Yang; Bin Hu; Zhi-yong Ma; Hong-ping Huang; Yuan Yu; Shen-pei Liu; Meng-ji Lu; Dong-liang Yang
Journal:  Virol Sin       Date:  2010-02-12       Impact factor: 4.327

2.  Antibody dependent cytotoxicity in chronic active liver disease.

Authors:  T Banciu; P Arcan
Journal:  Gastroenterol Jpn       Date:  1988-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.